Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc
KNBIF
Primary Symbol:
V.KNE
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired...
from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2181)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Nov 12, 2024 3:55pm
Acquistion
Why no revenue or ebitda for FB Dermatology S.R.L disclosed? How do we know if Kane paid a fair price?
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Nov 12, 2024 2:41pm
RE:I wonder....
The expectations that you don't like are really the estimates of how long it will take for the FDA to get it's act together and allow the acne and dispersin trials to start. kne does not
...more
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Nov 12, 2024 1:51pm
RE:RE:I wonder....
Very good news. We are expanding our product line, we are expanding our geographic footprint and all that at a, what seems, to be a decent cost. The most important part of it is that Dr
...more
(202)
•••
RoyMax123
X
View Profile
View Bullboard History
Comment by
RoyMax123
on Nov 12, 2024 1:26pm
RE:I wonder....
No 2 is done, so most likely No 1 will be announced shortly.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Nov 05, 2024 1:33pm
I wonder....
...if KNE set the expectations to high (again) for Q4...here's what they are targeting for Q4/2024 (from their September presentation): 1. Financing announcement 2. Potential M&A announcement
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 17, 2024 8:30am
New Press Release - Kane Biotech Announces Exclusive Distribution Agreement With XSONX
WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed an exclusive five year distribution agreement with XSONX LLC (“XSONX”) for Kane to distribute XSONX’s Wound Hygiene System in Canada, Australia...
read article.
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Oct 04, 2024 12:50pm
RE:New Press Release - Kane Biotech to Participate in a Multinational Corporate Collaboration Project
POC results will de-risk corporate hesitations prior to increased investment into a new product. It can also help define target markets and uncover potential flaws or new insights into a product to
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 03, 2024 8:30am
New Press Release - Kane Biotech to Participate in a Multinational Corporate Collaboration Project
WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and up to $75,000 in funding through the National Research Council of Canada Industrial Research Assistance...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 26, 2024 8:30am
New Press Release - Kane Biotech Announces Attendance at Upcoming Wound Care Conferences
WINNIPEG, Manitoba, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the Company will be showcasing its revyve™ Antimicrobial Wound Gel and revyve™ Antimicrobial Wound Gel Spray products at the following wound...
read article.
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Sep 20, 2024 6:57pm
RE:RE:RE:RE:RE:RE:RE:New Corporate Presentation
The exchange limits how much forward guidance you can provide without revenues. You think exactly $3M per product, per year is a scientific calculation? Wait for a few quarters to see how Revyve and
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Sep 19, 2024 11:07pm
RE:RE:RE:RE:RE:RE:New Corporate Presentation
Revenue guidance is welcomed, professional and appropriate. Its a solid objective to measure performance of the management team and if anything, seems low to me anyway. I hope Marc is under
...more
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Sep 19, 2024 5:37pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:New Corporate Presentation
You're right, they updated the presentation today, to Q4.
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Sep 19, 2024 5:34pm
RE:RE:RE:RE:RE:RE:RE:RE:New Corporate Presentation
The presentation says Sept.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Sep 19, 2024 2:52pm
RE:RE:RE:RE:RE:RE:RE:New Corporate Presentation
Absolutely agree but the news is likely going to be next month (ie.: next QTR)....
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >